Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bearish Options Active On Market Vectors Gold Miners ETF (GDX)

Page 1 of 2

Market Vectors Gold Miners ETF (NYSEARCA:GDX)Market Vectors Gold Miners ETF (NYSEARCA:GDX) – Big prints in Market Vectors Gold Miners ETF (NYSEARCA:GDX) put options on Tuesday morning indicate some traders are positioning for shares in the Market Vectors Gold Miners Index ETF to potentially drop to the lowest level since December of 2008. Shares in the ETF are off 3.0% today at $28.85 as of midday in New York. Volume in Market Vectors Gold Miners ETF (NYSEARCA:GDX) options is heaviest in the Jun $27 strike puts where nearly 40,000 puts have traded versus open interest of 16,819 contracts. It looks like the bulk of the volume was purchased for an average premium of $0.89 per contract. Put buyers stand ready to profit at June expiration should the price of the underlying plunge 9.5% from the current level to trade below the average breakeven price of $26.11 by expiration. Sizable prints in the Jun $27 puts helped push the put/call ratio on Market Vectors Gold Miners ETF (NYSEARCA:GDX) above 4.4 during the first half of the session.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX) – Shares in specialty pharmaceutical company, Pacira Pharmaceuticals Inc (NASDAQ:PCRX), are bouncing around on Tuesday, rising as much as 2.0% in the early going, before reversing gains to trade down 2.0% at $27.84 by 12:25 p.m. ET. The company reports first-quarter earnings ahead of the opening bell tomorrow. Options changing hands on Pacira this morning suggest one trader is positioning for Pacira Pharmaceuticals Inc (NASDAQ:PCRX) shares to approach record highs in the near term. It looks like more than 1,000 of the May $30 strike calls were purchased for an average premium of $0.90 each. The bullish strategy makes money if shares in the pharmaceutical company rally 11% over the current price of $27.84 to top the average breakeven price of $30.90 by expiration next week. Shares in Pacira Pharmaceuticals Inc (NASDAQ:PCRX) are up more than 180% since this time last year.

Page 1 of 2
Loading Comments...